PRESS RELEASE: Carina to Present Three Poster Presentations at AACR Annual Meeting 2024
ADELAIDE, AUSTRALIA, March 19, 2024 Carina Biotech to Present Three Poster Presentations at AACR Annual Meeting 2024 Carina Biotech Limited
PRESS RELEASE: Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial
ADELAIDE, AUSTRALIA, December 19, 2023 Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy First
PRESS RELEASE: Carina to present at 7th annual Cell and Gene Therapy World Asia 2023 Conference
ADELAIDE, AUSTRALIA, September 13, 2023 Carina Biotech (Carina) invited to present at 7th annual Cell and Gene Therapy World Asia
PRESS RELEASE: Carina Biotech to Present Preclinical Data at 8th CAR-TCR Summit
ADELAIDE, AUSTRALIA, August 21, 2023 Carina Biotech to Present Preclinical Data Evaluating LGR5-Targeted CAR-T Cell Therapy in Human Cancer Models
PRESS RELEASE: Carina Biotech Appoints Two New U.S. Based Biotechnology Executives to the Board of Directors
ADELAIDE, AUSTRALIA, June 5, 2023 Carina Biotech (Carina), a cell therapy immuno-oncology company, today announced the appointment of Michael S.
PRESS RELEASE: Carina Biotech to Participate in Three Upcoming Conferences
ADELAIDE, AUSTRALIA, May 25, 2023 Carina Biotech (Carina), a cell therapy immuno-oncology company, today announced that the management team will participate in the three
PRESS RELEASE: Carina Biotech to Present Details of Planned Phase 1/2a Clinical Trial at 2023 ASCO Annual Meeting
ADELAIDE, AUSTRALIA, April 2, 2023 Carina Biotech to Present Details of Planned Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell
PRESS RELEASE: Carina to present at AACR 2023
ADELAIDE, AUSTRALIA, March 22, 2023 Carina Biotech to Present Preclinical Data Evaluating LGR5-Targeted CAR-T Cell Therapy in Colorectal Cancer Models